Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

News | Cardiac Diagnostics

New Best Practices Help Manage Heart Attack Patients Without Significant Signs

April 15, 2019 — For the first time in the United States, doctors with the American Heart Association (AHA) have ...

April 15, 2019

Foreign-trained doctors now make up one-third of cardiologists in the United States and help make up for the U.S. overall shortage of physicians. Pictured here is co-author of this article Mandeep R. Mehra, MBBS, MSc, FRCP, who is an example of the contribution international physicians have made in the U.S. He is medical director of the Brigham and Women’s Hospital Heart and Vascular Center.

Feature | Cardiovascular Business | William W. Pinsky, M.D., FAAP, FACC, and Mandeep R. Mehra, MBBS, MSc , FRCP

Immigration is Essential to Filling U.S. Physician Demand

As we strive to process today’s successive news cycles involving negative reports about immigration, it is easy for many ...

April 15, 2019

Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack Endovascular System. This is a purpose-built dissection repair device implanted post-angioplasty in patients with peripheral arterial disease (PAD).

Technology | Peripheral Artery Disease (PAD)

FDA Clears Intact Vascular’s Tack Endovascular System

April 15, 2019 – Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack ...

April 15, 2019

Sponsored Content

Blog | Contrast Media Injectors

BLOG: Enhancing Efficiency and Patient Care with a Modern Injector

Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...

August 22, 2023

BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.

Technology | Cath Lab

Biotronik Begins U.S. Launch of PK Papyrus Covered Coronary Stent

April 15, 2019 — Biotronik began its U.S. commercial launch of the PK Papyrus covered coronary stent system for use in ...

April 15, 2019

News | Guidewires

Straight Tip Guidewires Will Continue to Lead Global Guidewire Market Demand

April 10, 2019 — According to a new research study, straight tip guidewires, with a current share of more than a third ...

April 10, 2019

News | Cath Lab

Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths

April 9, 2019 — A program designed to help heart attack patients with the transition from hospital to outpatient care ...

April 09, 2019

Sponsored Content

As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.

Blog | Enterprise Imaging

BLOG: The Power of Enterprise Imaging in Structural Heart Procedures

As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...

August 10, 2023

News | Heart Valve Technology | Jeff Zagoudis, Associate Editor

Mick Jagger Recovering After TAVR Procedure

April 8, 2019 — Rolling Stones frontman Mick Jagger is reportedly recovering after undergoing a transcatheter aortic ...

April 08, 2019

Technology | Cath Lab

TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy

April 8, 2019 — TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for ...

April 08, 2019

News | Ventricular Assist Devices (VAD)

Cardiogenic Shock Survival Rates Improve in Three Years Since Impella FDA Approval

April 5, 2019 — Three years ago this week, Abiomed's Impella heart pump received U.S. Food and Drug Administration (FDA) ...

April 05, 2019

Sponsored Content

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the wealth of technological advancements, bringing the necessary tools together in a streamlined workflow has remained a challenge for clinicians

Case Study | Baylor Scott and White Heart Hospital

Contemporary PCI: Utilizing State-of-the-Art Technology to Achieve the Best Outcomes

While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...

May 05, 2023

Technology | Radiation Dose Management

Omega Medical Imaging Launches AI-enabled FluoroShield for Radiation Reduction

April 4, 2019 — The U.S. Food and Drug Administration (FDA) granted Omega Medical Imaging 510(k) clearance to offer ...

April 04, 2019

Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting

News | Heart Valve Technology

TAVR Performs Well Compared to Surgical Aortic Valve Replacement in Low Risk Patients

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut ...

April 03, 2019

The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral Vascular's Covera Vascular Covered Stent for the treatment of a stenosis or blockage which has developed anywhere in the access circuit of patients on hemodialysis using an arteriovenous (AV) fistula.

Technology | Stents

New Indication Added for Covered Stent to Treat Hemodialysis AV Fistula

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...

April 03, 2019

Sponsored Content

Blog | Intra-Vascular Ultrasound (IVUS)

BLOG: Making a Case for the Variable Rate Contrast Injector

During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...

April 11, 2023

The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous Stent System intended to treat narrowed iliofemoral veins.

Technology | Venous Therapies

FDA Clears Venous Stent for the Iliofemoral Veins

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

April 03, 2019

Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.

Technology | Vascular Closure Devices

Large-Bore Vascular Closure Device Cleared by the FDA

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore ...

April 03, 2019

Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S. Food and Drug Administration (FDA) indication for treatment of de novo chronic total occlusion (CTO) lesions.

Technology

Resolute Integrity Now Indicated for CTOs

April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S ...

April 03, 2019